ODC1 and neoplasm: Some studies have shown that inhibition of ornithine decarboxylase (ODC), and/or treatment of polyamine transport inhibitors (PTIs), significantly reduces the tumor growth rate due to the enhanced anti-tumor immunity (64–66).